Jean-Marie Eveillard - First Eagle Investment Management
Holding/activity history for Eagle Pharmaceuticals Inc (EGRX)
← All EGRX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.04 | $36.03–70.13 · VW $50.49i | SEC | |
| 2018 Q3 | 213,822 | 0.04 | Reduce 5.53% | <0.01 | $64.51–85.66 · VW $73.64i | $14,824,000 | SEC |
| 2018 Q2 | 226,333 | 0.04 | Reduce 54.82% | 0.04 | $50.23–77.32 · VW $64.16i | $17,124,000 | SEC |
| 2018 Q1 | 500,922 | 0.07 | Reduce 16.72% | 0.01 | $51.27–67.50 · VW $57.70i | $26,394,000 | SEC |
| 2017 Q4 | 601,505 | 0.08 | $53.42 | $32,132,000 | SEC | ||
| 2017 Q3 | 601,505 | 0.08 | Reduce 7.67% | <0.01 | $45.05–83.80 · VW $56.78i | $35,874,000 | SEC |
| 2017 Q2 | 651,505 | 0.12 | Reduce 1.44% | <0.01 | $68.38–97.15 · VW $80.96i | $51,397,000 | SEC |
| 2017 Q1 | 661,005 | 0.14 | Add 4.13% | <0.01 | $61.10–86.00 · VW $74.78i | $54,824,000 | SEC |
| 2016 Q4 | 634,805 | 0.13 | Add 11.72% | 0.01 | $54.70–87.78 · VW $71.50i | $50,365,000 | SEC |
| 2016 Q3 | 568,205 | 0.10 | Buy | 0.10 | $38.20–71.37 · VW $56.33i | $39,774,000 | SEC |